Setback: HC rejects Sun Pharma plea against Hetero alleging trademark infringement of cancer drug Letroz Farhat Nasim6 Sept 2022 5:33 PM ISTNew Delhi: Holding that when the name is derived or coined from the name of the principal ingredient being used in the manufacture of the drug, no...
Novartis Gets CDSCO Panel Nod To Study Ianalumab Dr. Divya Colin4 Sept 2022 11:17 AM ISTNew Delhi: In a significant development, drug major Novartis has got a green signal from the Subject Expert Committee (SEC) functional under the...
Novartis: Scemblix approved in the EU for adults with chronic myeloid leukemia Kajal Rajput29 Aug 2022 3:03 PM ISTBasel: Novartis today announced that the European Commission (EC) has approved Scemblix (asciminib) for the treatment of adult patients with...
Novartis Sandoz division to go independent Ruchika Sharma25 Aug 2022 2:33 PM ISTThe standalone Sandoz would be headquartered in Switzerland and listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in...
Post USFDA nod, Bluebird Bio USD 2.8 million gene therapy becomes most expensive drug Ruchika Sharma19 Aug 2022 4:32 PM ISTBluebird has pitched Zynteglo as a potential one-time treatment that could do away with the need for transfusions, resulting in savings for patients...
Novartis Gets CDSCO Panel Nod To Study Crizanlizumab Dr. Divya Colin18 Aug 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Novartis has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
Novartis Lung cancer drug Canakinumab fails in Phase 3 trial Ruchika Sharma17 Aug 2022 4:15 PM ISTBasel: Novartis has recently announced that the Phase III CANOPY-A study evaluating adjuvant treatment with canakinumab (ACZ885), an inhibitor of...
Zolgensma gene therapy caused two fatalities from liver failure, reports Novartis Ruchika Sharma14 Aug 2022 2:00 PM ISTBasel: Novartis AG on Thursday reported two patient fatalities due to acute liver failure following treatment with Zolgensma gene therapy used to...
Novartis donates Rs 16 Crore gene therapy to 23 month old Spinal Muscular Atrophy Type 1 patient Roshni Dhar9 Aug 2022 6:00 PM ISTA 23-month-old baby with Spinal Muscular Atrophy (SMA) Type 1, received a new lease of life with Swiss drugmaker Novartis coming forward to donate...
Health Bulletin 9/ August/ 2022 Roshni Dhar9 Aug 2022 5:27 PM ISTHere are the Top Health stories for the day:Telangana baby with rare genetic disease administered Rs 16 crore drugA 23-month-old baby with Spinal...
Novartis donates Rs 16 crore drug to 23 month old Spinal Muscular Atrophy Type 1 patient MD Bureau8 Aug 2022 4:16 PM ISTAccording to Praveen, they had registered their daughter under Managed Access Programme of Novartis and they received the information that the company...
CDSCO panel rejects Novartis Phase III CT protocol for Lanalumab Rahul Verma30 July 2022 6:33 PM ISTCiting that the clinical trial protocol missed some inclusion/exclusion criteria, the Subject Expert Committee (SEC) functional under Central Drug...
